{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:15:06Z","timestamp":1789427706727,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T00:00:00Z","timestamp":1733097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["5900039"],"award-info":[{"award-number":["5900039"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["CUP C54I19002210001"],"award-info":[{"award-number":["CUP C54I19002210001"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011747","name":"Novo Nordisk Foundation Center for Basic Metabolic Research","doi-asserted-by":"publisher","award":["NNF 18 CC0034900"],"award-info":[{"award-number":["NNF 18 CC0034900"]}],"id":[{"id":"10.13039\/501100011747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005743","name":"Catholic University of the Sacred Heart","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001648","name":"European Foundation for the Study of Diabetes","doi-asserted-by":"publisher","award":["NNF21SA0072746"],"award-info":[{"award-number":["NNF21SA0072746"]}],"id":[{"id":"10.13039\/501100001648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.metabol.2024.156087","type":"journal-article","created":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T17:50:45Z","timestamp":1733075445000},"page":"156087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Human subjects with impaired beta-cell function and glucose tolerance have higher levels of intra-islet intact GLP-1"],"prefix":"10.1016","volume":"163","author":[{"given":"Teresa","family":"Mezza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolai J.","family":"Wewer Albrechtsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Di Giuseppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro Manuel","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Soldovieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gea","family":"Ciccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Quero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico Celestino","family":"Nista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Tondolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Pontecorvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Giaccari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens J.","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2024.156087_bb0005","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2024.156087_bb0010","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2337\/diabetes.54.2.482","article-title":"beta-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1","volume":"54","author":"Li","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2024.156087_bb0015","doi-asserted-by":"crossref","first-page":"10293","DOI":"10.1073\/pnas.162352599","article-title":"Disruption of PC1\/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects","volume":"99","author":"Zhu","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2024.156087_bb0020","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.metabol.2024.156087_bb0025","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1210\/en.2003-0323","article-title":"Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets","volume":"144","author":"Farilla","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2024.156087_bb0030","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.2337\/diabetes.48.12.2270","article-title":"Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats","volume":"48","author":"Xu","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2024.156087_bb0035","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2337\/diabetes.49.5.741","article-title":"Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas","volume":"49","author":"Stoffers","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2024.156087_bb0040","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/nm.2513","article-title":"Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells","volume":"17","author":"Ellingsgaard","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2024.156087_bb0045","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1007\/s00125-012-2716-9","article-title":"A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets","volume":"55","author":"Marchetti","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2024.156087_bb0050","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1172\/JCI112855","article-title":"Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas","volume":"79","author":"Mojsov","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2024.156087_bb0055","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00006676-199508000-00014","article-title":"The effects of glucagon-like peptide-I (GLP-I) on hormone secretion from isolated human pancreatic islets","volume":"11","author":"Fehmann","year":"1995","journal-title":"Pancreas"},{"key":"10.1016\/j.metabol.2024.156087_bb0060","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00125-011-2080-1","article-title":"Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomys obesus\u2014an adaptive response to hyperglycaemia?","volume":"54","author":"Hansen","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2024.156087_bb0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1080\/19382014.2021.1889941","article-title":"Evidence for the existence and potential roles of intra-islet glucagon-like peptide-1","volume":"13","author":"Campbell","year":"2021","journal-title":"Islets"},{"key":"10.1016\/j.metabol.2024.156087_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101014","article-title":"Human islets contain a subpopulation of glucagon-like peptide-1 secreting alpha cells that is increased in type 2 diabetes","volume":"39","author":"Campbell","year":"2020","journal-title":"Mol Metab"},{"key":"10.1016\/j.metabol.2024.156087_bb0075","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1073\/pnas.0237106100","article-title":"Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice","volume":"100","author":"Gelling","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2024.156087_bb0080","doi-asserted-by":"crossref","first-page":"E695","DOI":"10.1152\/ajpendo.00082.2009","article-title":"Pancreatic beta-cell overexpression of the glucagon receptor gene results in enhanced beta-cell function and mass","volume":"297","author":"Gelling","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2024.156087_bb0085","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.2337\/db06-0307","article-title":"Glucagon receptor knockout mice display increased insulin sensitivity and impaired beta-cell function","volume":"55","author":"Sorensen","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2024.156087_bb0090","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1016\/j.celrep.2017.03.005","article-title":"Pancreatic alpha cell-derived glucagon-related peptides are required for beta cell adaptation and glucose homeostasis","volume":"18","author":"Traub","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.metabol.2024.156087_bb0095","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1172\/JCI7456","article-title":"Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats","volume":"105","author":"Nie","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2024.156087_bb0100","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1007\/s12010-022-04089-y","article-title":"Islet MC4R regulates PC1\/3 to improve insulin secretion in T2DM mice via the cAMP and beta-arrestin-1 pathways","volume":"194","author":"Ni","year":"2022","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.metabol.2024.156087_bb0105","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cmet.2017.02.008","article-title":"The role of pancreatic preproglucagon in glucose homeostasis in mice","volume":"25","author":"Chambers","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2024.156087_bb0110","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.cmet.2019.08.009","article-title":"Gut-proglucagon-derived peptides are essential for regulating glucose homeostasis in mice","volume":"30","author":"Song","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2024.156087_bb0115","doi-asserted-by":"crossref","first-page":"E93","DOI":"10.1152\/ajpendo.00198.2017","article-title":"Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis","volume":"314","author":"Galsgaard","year":"2018","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2024.156087_bb0120","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.celrep.2018.10.018","article-title":"Insulin secretion depends on intra-islet glucagon signaling","volume":"25","author":"Svendsen","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.metabol.2024.156087_bb0125","doi-asserted-by":"crossref","first-page":"18827","DOI":"10.1016\/S0021-9258(17)32241-X","article-title":"Proglucagon processing in porcine and human pancreas","volume":"269","author":"Holst","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2024.156087_bb0130","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2337\/db13-1013","article-title":"Insulin resistance alters islet morphology in nondiabetic humans","volume":"63","author":"Mezza","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2024.156087_bb0135","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.tem.2020.07.003","article-title":"Endocrine and metabolic insights from pancreatic surgery","volume":"31","author":"Mezza","year":"2020","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2024.156087_bb0140","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2337\/db18-0856","article-title":"beta-cell fate in human insulin resistance and type 2 diabetes: a perspective on islet plasticity","volume":"68","author":"Mezza","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2024.156087_bb0145","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00125-022-05814-2","article-title":"Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes","volume":"66","author":"Brusco","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2024.156087_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154414","article-title":"Noradrenergic fibers are associated with beta-cell dedifferentiation and impaired beta-cell function in humans","volume":"114","author":"Cinti","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2024.156087_bb0155","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175133","article-title":"Reduced incretin effect precedes diabetes development following duodenopancreatectomy in individuals without diabetes","volume":"134","author":"Di Giuseppe","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2024.156087_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101754","article-title":"An update on pancreatic regeneration mechanisms: searching for paths to a cure for type 2 diabetes","volume":"74","author":"Soldovieri","year":"2023","journal-title":"Mol Metab"},{"key":"10.1016\/j.metabol.2024.156087_bb0165","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc19-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019","volume":"42","author":"American Diabetes A","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2024.156087_bb0170","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.2337\/dc12-0811","article-title":"Removal of duodenum elicits GLP-1 secretion","volume":"36","author":"Muscogiuri","year":"2013","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.metabol.2024.156087_bb0175","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.2337\/db18-0279","article-title":"Increased beta cell workload modulates proinsulin\/insulin ratio in humans","volume":"67","author":"Mezza","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2024.156087_bb0180","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1172\/JCI115012","article-title":"Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine","volume":"87","author":"Orskov","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2024.156087_bb0185","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2337\/diab.43.4.535","article-title":"Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans","volume":"43","author":"Orskov","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2024.156087_bb0190","doi-asserted-by":"crossref","first-page":"E284","DOI":"10.1152\/ajpendo.00005.2017","article-title":"A sandwich ELISA for measurement of the primary glucagon-like peptide-1 metabolite","volume":"313","author":"Wewer Albrechtsen","year":"2017","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2024.156087_bb0195","first-page":"E214","article-title":"Glucose clamp technique: a method for quantifying insulin secretion and resistance","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am J Physiol"},{"key":"10.1016\/j.metabol.2024.156087_bb0200","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00000658-198009000-00005","article-title":"Preservation of the pylorus in pancreaticoduodenectomy a follow-up evaluation","volume":"192","author":"Traverso","year":"1980","journal-title":"Ann Surg"},{"key":"10.1016\/j.metabol.2024.156087_bb0205","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00125-009-1647-6","article-title":"Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance","volume":"53","author":"Mari","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2024.156087_bb0210","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1210\/jc.2015-2802","article-title":"beta-cell glucose sensitivity is linked to insulin\/glucagon bihormonal cells in nondiabetic humans","volume":"101","author":"Mezza","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2024.156087_bb0215","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.2337\/diabetes.51.2007.S221","article-title":"Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation","volume":"51","author":"Mari","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2024.156087_bb0220","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1530\/EC-14-0126","article-title":"Stability of glucagon-like peptide 1 and glucagon in human plasma","volume":"4","author":"Wewer Albrechtsen","year":"2015","journal-title":"Endocr Connect"},{"key":"10.1016\/j.metabol.2024.156087_bb0225","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/clinchem\/45.4.549","article-title":"Library of sequence-specific radioimmunoassays for human chromogranin A","volume":"45","author":"Jensen","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.metabol.2024.156087_bb0230","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1096\/fj.201700061RR","article-title":"Interleukin 6 protects pancreatic beta cells from apoptosis by stimulation of autophagy","volume":"31","author":"Linnemann","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2024.156087_bb0235","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/JOE-11-0094","article-title":"Processing of proglucagon to GLP-1 in pancreatic alpha-cells: is this a paracrine mechanism enabling GLP-1 to act on beta-cells?","volume":"211","author":"Whalley","year":"2011","journal-title":"J Endocrinol"},{"key":"10.1016\/j.metabol.2024.156087_bb0240","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1021\/acs.jproteome.1c00463","article-title":"The human and mouse islet peptidome: effects of obesity and type 2 diabetes, and assessment of intraislet production of glucagon-like peptide-1","volume":"20","author":"Galvin","year":"2021","journal-title":"J Proteome Res"},{"key":"10.1016\/j.metabol.2024.156087_bb0245","article-title":"Fam3a-mediated prohormone convertase switch in alpha-cells regulates pancreatic GLP-1 production in an Nr4a2-Foxa2-dependent manner","author":"Wang","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2024.156087_bb0250","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2337\/db22-0784","article-title":"Glucagon acting at the GLP-1 receptor contributes to beta-cell regeneration induced by glucagon receptor antagonism in diabetic mice","volume":"72","author":"Wei","year":"2023","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2024.156087_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155332","article-title":"Pharmacotherapy of type 2 diabetes: an update and future directions","volume":"137","author":"DeMarsilis","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2024.156087_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155689","article-title":"Milestones in the journey towards addressing obesity; past trials and triumphs, recent breakthroughs, and an exciting future in the era of emerging effective medical therapies and integration of effective medical therapies with metabolic surgery","volume":"148","author":"Kokkorakis","year":"2023","journal-title":"Metabolism"}],"updated-by":[{"DOI":"10.1016\/j.metabol.2025.156372","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000}}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049524003159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049524003159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:16:10Z","timestamp":1777425370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049524003159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":52,"alternative-id":["S0026049524003159"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2024.156087","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human subjects with impaired beta-cell function and glucose tolerance have higher levels of intra-islet intact GLP-1","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2024.156087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"156087"}}